Back to search

United Kingdom· GB-APID-13481011000001109

Chlorpromazine 25mg tablets

A chlorpromazine product containing chlorpromazine, registered in United Kingdom by Almus Pharmaceuticals Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC N05AA01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedChlorpromazine 25mg tabletsATCN05AA01REGISTER NO.GB-APID-1348101100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Chlorpromazine is registered in 10 of 19 countries.

Countries holding a registration under ATC N05AA01 (chlorpromazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose

Chlorpromazine · ATC N05AA01

10 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Ireland
  • Italyprice
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chlorpromazine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.61 in France to $2.57 in United States — a ×4.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Chlorpromazine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • US United States$2.57 (acquisition cost)
  • IT Italy$0.63
  • FR France$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Chlorpromazine
Manufacturer
Almus Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
N05AA01
ATC class
Chlorpromazine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    05060057403839

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

464 interactions on record for chlorpromazine.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chlorpromazine · interactions on record

464 records

  • 49 severe
  • 301 moderate
  • 10 minor
  • 39 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe

65 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chlorpromazine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorpromazine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Cyprus · Chlorpromazine Remedica
  • Spain · Largactil
  • France · Largactil
  • Greece · Solidon, Zuledine
  • Ireland · Chloropromazine Pinewood Laboratories, Clonactil
  • Italy · Largactil
  • Malta · Chlorpromazine Remedica
  • Poland · Fenactil
  • Portugal · Largactil, Largactil Im

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aed06209-6e02-45cb-841f-71918a0b5d99
GET /v1/drugs/aed06209-6e02-45cb-841f-71918a0b5d99?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "13481011000001109",
  "desc": "Chlorpromazine 25mg tablets (Almus Pharmaceuticals Ltd)",
  "form": "Oral tablet",
  "vpid": "42269111000001102",
  "source": "dmd",
  "vtm_id": "775216005",
  "strength": "25 mg",
  "substance": "Chlorpromazine",
  "ingredient": "Chlorpromazine hydrochloride",
  "supplier_code": "9507111000001106"
}

See everything about chlorpromazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.